Technical Analysis for QNRX - Quoin Pharmaceuticals, Ltd.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | 1.80% | |
| Weak + Overbought | Other | 1.80% | |
| Inside Day | Range Contraction | 1.80% | |
| Wide Bands | Range Expansion | 1.80% | |
| Overbought Stochastic | Strength | 1.80% | |
| Weak + Overbought | Other | 1.58% | |
| Overbought Stochastic | Strength | 1.58% | |
| Stochastic Sell Signal | Bearish | 0.08% | |
| 20 DMA Support | Bullish | 0.08% | |
| Weak + Overbought | Other | 0.08% |
| Alert | Time |
|---|---|
| 10 DMA Support | about 3 hours ago |
| Up 3% | about 3 hours ago |
| Fell Below Previous Day's Low | about 3 hours ago |
| Up 2% | about 3 hours ago |
| Up 1% | about 3 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Founded in 2018 as Quoin Pharmaceuticals Inc. by Michael Myers Ph.D. and Denise Carter, Quoin is an emerging specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities and care teams. Quoin’s innovative pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa and others.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Pharmaceutical Therapeutic Products Genodermatoses Epidermolysis Bullosa Netherton Syndrome Rare And Orphan Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Pharmaceutical Therapeutic Products Genodermatoses Epidermolysis Bullosa Netherton Syndrome Rare And Orphan Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 110.4192 |
| 52 Week Low | 0.6029 |
| Average Volume | 188,504 |
| 200-Day Moving Average | 3.57 |
| 50-Day Moving Average | 0.84 |
| 20-Day Moving Average | 0.72 |
| 10-Day Moving Average | 0.77 |
| Average True Range | 0.07 |
| RSI (14) | 43.50 |
| ADX | 10.12 |
| +DI | 23.93 |
| -DI | 19.86 |
| Chandelier Exit (Long, 3 ATRs) | 0.61 |
| Chandelier Exit (Short, 3 ATRs) | 0.81 |
| Upper Bollinger Bands | 0.83 |
| Lower Bollinger Band | 0.61 |
| Percent B (%b) | 0.74 |
| BandWidth | 30.52 |
| MACD Line | -0.05 |
| MACD Signal Line | -0.08 |
| MACD Histogram | 0.0351 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.82 | ||||
| Resistance 3 (R3) | 0.82 | 0.81 | 0.81 | ||
| Resistance 2 (R2) | 0.81 | 0.80 | 0.81 | 0.81 | |
| Resistance 1 (R1) | 0.79 | 0.79 | 0.79 | 0.79 | 0.81 |
| Pivot Point | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 |
| Support 1 (S1) | 0.76 | 0.77 | 0.76 | 0.76 | 0.74 |
| Support 2 (S2) | 0.75 | 0.76 | 0.75 | 0.74 | |
| Support 3 (S3) | 0.73 | 0.75 | 0.74 | ||
| Support 4 (S4) | 0.73 |
